Alexandria Real Estate Equities, Inc. (ARE)
Summary
ARE Chart
People also search for
Alexandria Stock Soars 10.9% in a Month: Will the Trend Continue?
ARE shares jump 10.9% in a month as leasing strength, Megacampus exposure and $4.17B liquidity support cash flow amid uneven demand.
Alexandria Or Healthpeak? Your Risk Tolerance May Determine The Winner
Healthpeak Properties offers a diversified, growth-oriented REIT portfolio with 40% life science exposure and robust 2026 FFO guidance of $1.71–$1.75 per share. DOC maintains conservative 37.3% leverage, investment-grade ratings with a stable outlook, and a well-covered 6.2% monthly dividend supported by a 70% payout ratio. Alexandria Real Estate is in portfolio contraction mode, facing sector oversupply and negative re-leasing spreads, with 2026 FFO guidance annualized at $5.80 per share.
Alexandria Real Estate: Thesis Has Evolved, Same Hold, Different Goalposts
Alexandria Real Estate Equities remains rated Hold as improved policy clarity and a recovering disposition market are offset by new operational headwinds. NIH indirect cost cap removal and better asset sale prospects reduce tail risks, but occupancy and NOI guidance have been revised downward amid weak leasing trends. A significant 2027 lease expiration wall (~$97m annual rent) now threatens to extend FFO pressures beyond Q4 2026, clouding recovery visibility.
Alexandria Real Estate Equities, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MSH Michelle S. Hickox FIRST FINANCIAL BANKSHARES Inc. | 116,813 | $8.39M | $5.64M | -$2.76M | -32.84% |
| CE Curtis Ellergodt Rothschild Investment LLC | 267 | $22,251.78 | $12,882.75 | -$9,369.03 | -42.1% |
| WH William Herlihy RESOURCES MANAGEMENT Corp. /CT/ /ADV | 25 | $2,083.5 | $1,206.25 | -$877.25 | -42.1% |
| ABB Alexander Bjornager Bonde Danske Bank A/S | 800 | $39,152 | $38,600 | -$552 | -1.41% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 237 | $30,890.72 | $11,458.95 | -$19,431.77 | -62.9% |
Alexandria Real Estate Equities, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| RK Ronald Kamdem Morgan Stanley | -962.03 | $50,766.24 | $48,082.18 | $2,684.06 | 5.29% |
Alexandria Real Estate Equities, Inc. (ARE) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Alexandria Real Estate Equities, Inc. ever had a stock split?
Alexandria Real Estate Equities, Inc. Profile
| Office REITs Industry | Real Estate Sector | Mr. Joel S. Marcus CPA, J.D. CEO | NYSE Exchange | 015271109 CUSIP |
| BR Country | 514 Employees | 30 Jun 2026 Last Dividend | 24 Apr 2006 Last Split | 27 May 1997 IPO Date |
Overview
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an esteemed member of the S&P 500, stands as a leader in the mission-driven life science Real Estate Investment Trust (REIT) sector, committed to making a profound and enduring impact on the world. Founded in 1994, Alexandria established the life science real estate niche and has since maintained its position as the foremost and most experienced owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses. These campuses are strategically located in AAA innovation cluster locations across the United States, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. With a substantial market capitalization totaling $33.1 billion and an extensive asset base spanning 73.5 million square feet in North America as of December 31, 2023, Alexandria exemplifies a remarkable track record. This track record includes creating Class A/A+ properties that foster highly dynamic and collaborative environments crucial for attracting and retaining top-tier talent and supporting the success of its innovative tenants. Additionally, through its venture capital platform, Alexandria actively provides strategic capital to groundbreaking companies in life science, agrifoodtech, climate innovation, and technology sectors, further demonstrating its comprehensive commitment to fostering growth and excellence within these critical areas of innovation.
Products and Services
- Life Science, Agtech, and Technology Real Estate:
- Class A/A+ Property Development:
- Venture Capital Investments:
Alexandria excels in developing, owning, and operating collaborative mega campuses in AAA innovation cluster locations. These campuses are tailored for companies in the life sciences, agtech, and advanced technology sectors, offering state-of-the-art facilities that promote productivity, efficiency, creativity, and success.
The company has a proven expertise in creating Class A/A+ properties, which are central to its strategy of clustering such properties within mega campuses. These developments not only meet the highest standards of quality and environmental sustainability but also provide tenants with the necessary infrastructure to thrive and innovate.
Alexandria extends its impact beyond real estate through strategic venture capital investments in transformative companies within the life science, agrifoodtech, climate innovation, and technology sectors. This venture capital platform enables Alexandria to support the growth and development of these sectors by providing critical capital and resources.
